LENSAR Inc (LNSR)

Currency in USD
12.630
-0.030(-0.24%)
Real-time Data·
LNSR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LNSR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.58012.680
52 wk Range
3.80017.310
Key Statistics
Prev. Close
12.66
Open
12.68
Day's Range
12.58-12.68
52 wk Range
3.8-17.31
Volume
19.93K
Average Volume (3m)
96.41K
1-Year Change
168.22%
Book Value / Share
-1.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LNSR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.000
Upside
+18.76%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

LENSAR Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

LENSAR Inc Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LENSAR Inc Earnings Call Summary for Q4/2024

  • Q4 2024 revenue grew 38% YoY to $16.7M, beating expectations, but EPS missed at -$1.61 vs -$0.18 forecast
  • Positive adjusted EBITDA of $478,000 achieved in Q4; company expects >27% revenue growth and positive full-year adjusted EBITDA in 2025
  • Stock rose 0.84% premarket despite EPS miss, reflecting optimism on revenue growth and operational improvements
  • CEO highlighted "outstanding" 2024 performance and strategic expansion; CFO confident in positive 2025 adjusted EBITDA
  • Analysts bullish with $10-$12 price targets; company maintains strong financial flexibility with healthy current ratio
Last Updated: 27/02/2025, 15:32
Read Full Transcript

Compare LNSR to Peers and Sector

Metrics to compare
LNSR
Peers
Sector
Relationship
P/E Ratio
−3.0x−3.7x−0.6x
PEG Ratio
0.02−0.200.00
Price/Book
−6.5x2.9x2.6x
Price / LTM Sales
2.6x3.6x3.3x
Upside (Analyst Target)
18.5%26.2%39.0%
Fair Value Upside
Unlock−0.9%4.9%Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.000
(+18.76% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.15 / -0.07
Revenue / Forecast
13.94M / 16.55M
EPS Revisions
Last 90 days

LNSR Income Statement

People Also Watch

46.88
PDEX
+1.44%
15.87
TSSI
+6.74%
125.56
CRCL
+0.26%
13.920
CRMD
+1.38%
36.61
RVMD
+2.64%

FAQ

What Stock Exchange Does LENSAR Trade On?

LENSAR is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LENSAR?

The stock symbol for LENSAR is "LNSR."

What Is the LENSAR Market Cap?

As of today, LENSAR market cap is 150.69M.

What Is LENSAR's Earnings Per Share (TTM)?

The LENSAR EPS (TTM) is -4.20.

When Is the Next LENSAR Earnings Date?

LENSAR will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is LNSR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has LENSAR Stock Split?

LENSAR has split 0 times.

How Many Employees Does LENSAR Have?

LENSAR has 140 employees.

What is the current trading status of LENSAR (LNSR)?

As of 26 Aug 2025, LENSAR (LNSR) is trading at a price of 12.63, with a previous close of 12.66. The stock has fluctuated within a day range of 12.58 to 12.68, while its 52-week range spans from 3.80 to 17.31.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.